Brandinium

Trademark search for:

BENZACLIN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 1997-10-14 — Application filed
  • 1998-01-07 — Approved for pub - principal register
  • 1998-02-07 — Notice of publication
  • 1998-03-10 — Published for opposition
  • 1998-06-02 — Noa mailed - sou required from applicant
  • 1998-11-13 — Sou extension 1 filed
  • 1998-12-21 — Sou extension 1 granted
  • 1999-05-03 — Sou extension 2 filed
  • 1999-05-28 — Sou extension 2 granted
  • 1999-11-22 — Sou extension 3 filed
  • 1999-12-29 — Sou extension 3 granted
  • 2000-05-16 — Sou extension 4 filed
  • 2000-07-11 — Sou extension 4 granted
  • 2000-11-30 — Sou extension 5 filed
  • 2001-01-28 — Sou extension 5 granted
  • 2001-04-10 — Use amendment filed
  • 2001-06-08 — Statement of use processing complete
  • 2001-06-20 — Allowed principal register - sou accepted
  • 2001-10-30 — Registered-principal register
  • 2005-08-24 — Teas change of correspondence received
  • 2007-01-26 — Case file in ticrs
  • 2007-10-23 — Teas section 8 & 15 received
  • 2007-10-29 — Assigned to paralegal
  • 2007-11-12 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2011-10-12 — Teas section 8 & 9 received
  • 2011-10-13 — Registered and renewed (first renewal - 10 yrs)
  • 2011-10-13 — Registered - sec. 8 (10-yr) accepted/sec. 9 granted
  • 2012-01-23 — Teas revoke/app/change addr of atty/dom rep received
  • 2012-01-23 — Attorney/dom.rep.revoked and/or appointed
  • 2012-01-25 — Automatic update of assignment of ownership
  • 2012-08-01 — Assignment of ownership not updated automatically
  • 2012-08-15 — Assignment of ownership not updated automatically
  • 2014-01-22 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-01-22 — Attorney/dom.rep.revoked and/or appointed
  • 2015-01-21 — Assignment of ownership not updated automatically
  • 2016-03-03 — Teas change of correspondence received
  • 2016-12-07 — Automatic update of assignment of ownership
  • 2017-01-11 — Automatic update of assignment of ownership
  • 2018-02-21 — Automatic update of assignment of ownership
  • 2018-10-16 — Teas revoke/app/change addr of atty/dom rep received
  • 2018-10-16 — Attorney/dom.rep.revoked and/or appointed
  • 2019-03-20 — Automatic update of assignment of ownership
  • 2019-07-10 — Assignment of ownership not updated automatically
  • 2020-05-03 — Teas change of owner address received
  • 2020-05-03 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-05-03 — Attorney/dom.rep.revoked and/or appointed
  • 2020-05-03 — Teas change of correspondence received
  • 2020-05-03 — Applicant/correspondence changes (non-responsive) entered
  • 2020-10-30 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2022-05-13 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2022-05-13 — Final status recorded
  • 2025-04-16 — Assignment of ownership not updated automatically

Owner Information

BAUSCH HEALTH IRELAND LIMITED
DUBLIN IE
VALEANT PHARMACEUTICALS IRELAND LIMITED
DUBLIN IE
VALEANT PHARMACEUTICALS LUXEMBOURG S.À.R.L
LUXEMBOURG CITY LU
VALEANT HOLDINGS IRELAND
DUBLIN IE
VALEANT INTERNATIONAL (BARBADOS) SRL
CHRIST CHURCH BB
Aventis Pharmaceuticals Inc.
BRIDGEWATER , NJ
Dermik Laboratories, Inc.
Collegeville , PA
Dermik Laboratories, Inc.
Collegeville , PA
Dermik Laboratories, Inc.
Collegeville , PA

Correspondent

John F. Ward Bausch Health
1400 N. Goodman Street
Law Department
Rochester, NY 14609

Filing Details

Filing Date:
1997-10-14
Status Date:
2022-05-13
Category:
Pharmaceuticals
Filing Year:
1997

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.